Wells Fargo & Company Issues Positive Forecast for Smartstop Self Storage REIT (NYSE:SMA) Stock Price

Smartstop Self Storage REIT (NYSE:SMA) had its price target upped by equities research analysts at Wells Fargo & Company from $30.00 to $32.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has an “equal weight” rating on the healthcare company’s stock. Wells Fargo & Company‘s price target indicates a potential upside of 4.15% from the stock’s previous close.

SMA has been the topic of a number of other research reports. Scotiabank upgraded shares of Smartstop Self Storage REIT to a “strong-buy” rating in a report on Thursday, March 19th. JPMorgan Chase & Co. decreased their price target on shares of Smartstop Self Storage REIT from $35.00 to $32.00 and set an “underweight” rating on the stock in a report on Monday, March 23rd. Weiss Ratings upgraded shares of Smartstop Self Storage REIT from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Zacks Research upgraded shares of Smartstop Self Storage REIT from a “strong sell” rating to a “hold” rating in a report on Friday, May 8th. Finally, Robert W. Baird decreased their price target on shares of Smartstop Self Storage REIT from $37.00 to $36.00 and set an “outperform” rating on the stock in a report on Wednesday, March 11th. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $37.17.

Smartstop Self Storage REIT Trading Down 1.7%

Shares of SMA traded down $0.53 during mid-day trading on Monday, reaching $30.73. The company had a trading volume of 83,213 shares, compared to its average volume of 826,431. The stock has a market cap of $1.70 billion, a price-to-earnings ratio of 204.77 and a beta of 0.69. The firm has a fifty day simple moving average of $31.33 and a 200-day simple moving average of $31.97. Smartstop Self Storage REIT has a fifty-two week low of $29.41 and a fifty-two week high of $39.77. The company has a current ratio of 5.33, a quick ratio of 5.33 and a debt-to-equity ratio of 0.86.

Smartstop Self Storage REIT (NYSE:SMA) last announced its quarterly earnings results on Wednesday, May 6th. The healthcare company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.01. The company had revenue of $78.31 million for the quarter, compared to analyst estimates of $72.56 million. Smartstop Self Storage REIT had a net margin of 4.38% and a return on equity of 1.00%. The company’s revenue for the quarter was up 19.7% on a year-over-year basis. Smartstop Self Storage REIT has set its FY 2026 guidance at 1.940-2.040 EPS. On average, sell-side analysts anticipate that Smartstop Self Storage REIT will post 2.02 EPS for the current fiscal year.

Hedge Funds Weigh In On Smartstop Self Storage REIT

Hedge funds have recently made changes to their positions in the business. Creative Financial Designs Inc. ADV purchased a new position in shares of Smartstop Self Storage REIT in the 4th quarter valued at $25,000. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Smartstop Self Storage REIT during the 3rd quarter worth $26,000. Beacon Capital Management Inc. purchased a new stake in Smartstop Self Storage REIT during the 4th quarter worth $26,000. Northwestern Mutual Wealth Management Co. purchased a new stake in Smartstop Self Storage REIT during the 4th quarter worth $27,000. Finally, Assetmark Inc. purchased a new stake in Smartstop Self Storage REIT during the 4th quarter worth $31,000.

About Smartstop Self Storage REIT

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.